Spironolactone Ceva (spironolactone) – Conditions or restrictions regarding supply and use - QC03DA01
Updated on site: 09-Feb-2018
|Ravimi nimetus:||Spironolactone Ceva|
|Tootja:||Ceva Sante Animale|
A.MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Name and address of the manufacturer responsible for batch release
Ceva Santé Animale Z.I. Très le Bois 22600 Loudéac France
- Cardalis - benazepril hydrochloride /spironolactone
Retseptiravimite loetelu. Toimeaine: "Spironolactone"
B.CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
Veterinary medicinal product subject to prescription.
C.STATEMENT OF THE MRLs
D. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION
Ceva Santé Animale ensures that the system of pharmacovigilance, as described in Part I of the marketing authorisation application, is in place and functioning before and whilst the veterinary medicinal product is on the market.